<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Ofatumumab studie 56 http:&#x2F;&#x2F;clinicaltrials.gov&#x2F;ct2&#x2F;show&#x2F;NCT01329900?term=ofatumumab&amp;rank=23]]></title><description><![CDATA[<p dir="auto">Ofatumumab studie 56 <a href="http://clinicaltrials.gov/ct2/show/NCT01329900?term=ofatumumab&amp;rank=23" rel="nofollow ugc">http://clinicaltrials.gov/ct2/show/NCT01329900?term=ofatumumab&amp;rank=23</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/448340/ofatumumab-studie-56-httpclinicaltrialsgovct2shownct01329900termofatumumabrank23</link><generator>RSS for Node</generator><lastBuildDate>Sat, 20 Jun 2026 10:25:24 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/448340.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 07 Apr 2011 05:39:37 GMT</pubDate><ttl>60</ttl></channel></rss>